Overview

A Phase 1 Open Label Study of the Safety and Tolerability of Oral ICM20 in Adults

Status:
Not yet recruiting
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
A Phase 1 Non-Randomized Open Label Study of Oral ICM20
Phase:
Phase 1
Details
Lead Sponsor:
IC-MedTech Corporation
Treatments:
Benzonidazole